Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Novartis expands partnership with MMV for the development of antimalarial compound KAF-156

June 16, 2016

BARDA awards next option on contract to Atox Bio to support development of AB-103

June 16, 2016

FDA grants QIDP designation to Amplyx Pharmaceuticals' APX-001

June 16, 2016

EnBiotix signs deal with Mayo Clinic to continue development of EPP-001

June 15, 2016

FDA approves Vaxchora cholera vaccine

June 13, 2016

Arrowhead Pharmaceuticals begins phase I/II trial of ARC-521

June 10, 2016

Regulus Therapeutics announces phase II results on RG-101

June 8, 2016

Fusion peptide of HIV-1 as target for vaccine design

June 7, 2016

Vonosap and Vonopion packs launched in Japan for H. pylori eradication

June 7, 2016

GeoVax begins HBV vaccine development program

June 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...